NEW YORK, Feb 21 – Celera and Diversa said Wednesday they have sequenced the genome of Streptomyces diversa , a proprietary strain of Streptomyces bacteria that belongs to the group of microorganisms that produce most antibiotics.

The companies began sequencing this genome under a multi-year, cross-royalty agreement announced in December 2000, in which the two will collaborate to sequence the genomes of different microorganisms in Diversa’s Pathway Llbraries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.